Sunday, September 20, 2020 7:31:21 AM
A few questions for Andrew while
trying to adhere to shareholder guidelines.
1. Is OPTI on target with their earlier revenue estimates via PR?
2. Does OPTI have any future products in the works?
OR upgraded features to existing products?
(I saw a light mechanism that auto shut off
after area sanitization was complete. Product
had some type of sensor on it). Anything you can
tell us in this area of development?
3. Trying to get a bit of an understanding on
why there is a so little product availability
via the website. Are you able to receive and ship
as many units as desired by present demand?
Has the focus shifted to satisfying distributors
vs retail for the time being. Anything you can say
about demand, production, and/or focus?
4. Being in the early stages of development. Have you
established and hired anyone yet to oversee sales and/or
distributorships under the CEOs oversight? Or is Roger P.
performing that function for now as well?
5. As head of IR, can you comment on a venue you might establish
for future communications? Maybe YouTube, company website, Twitter, Facebook? Maybe open to Q & A session on topics that are within bounds via email?
May you have continued success,
OPTI shareholders.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM